Copyright
©The Author(s) 2019.
World J Clin Cases. Jul 6, 2019; 7(13): 1623-1633
Published online Jul 6, 2019. doi: 10.12998/wjcc.v7.i13.1623
Published online Jul 6, 2019. doi: 10.12998/wjcc.v7.i13.1623
Risk score | Rate of RBES (n = 345) | Rate of RBES (n = 162) | Risk | Point | Development cohort Rate of RBES | Validation cohort Rate of RBES |
0 | 2.6% (1/38) | 0% (0/11) | Low | 0-2 | 1.0% (1/107) | 0% (0/43) |
1 | 0% (0/67) | 0% (0/28) | Intermediate | 3-5 | 12.2% (26/213) | 7.3% (8/110) |
2 | 0% (0/2) | 0% (0/4) | High | 6-8 | 76.0% (19/25) | 33.3% (3/9) |
3 | 6.7% (10/149) | 6% (5/84) | ||||
4 | 14.3% (4/28) | 0% (0/8) | ||||
5 | 33.3% (12/36) | 16.7% (3/18) | ||||
6 | 73.7% (14/19) | 14.3% (1/7) | ||||
7 | 100% (3/3) | 100% (1/1) | ||||
8 | 66.7% (2/3) | 100% (1/1) |
- Citation: Lu Q, Lei TT, Wang YL, Yan HL, Lin B, Zhu LL, Ma HS, Yang JL. Development and validation of a model to determine risk of refractory benign esophageal strictures. World J Clin Cases 2019; 7(13): 1623-1633
- URL: https://www.wjgnet.com/2307-8960/full/v7/i13/1623.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v7.i13.1623